These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2404626)

  • 21. Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate.
    László FA; Csáti S; Baláspiri L
    Acta Endocrinol (Copenh); 1984 May; 106(1):56-60. PubMed ID: 6730855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desensitization of renal vasopressin-stimulated adenylate cyclase by a vasopressor and antidiuretic antagonist, [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-ethyl)-D-tyrosine, 4-valine]arginine vasopressin.
    Chang P; Kimura K
    Biochem Biophys Res Commun; 1987 Apr; 144(2):770-8. PubMed ID: 3579941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A V1 vasopressin receptor antagonist has nonspecific neurodepressant actions in the spinal cord.
    Porter JP; Brody MJ
    Neuroendocrinology; 1986; 43(1):75-8. PubMed ID: 3012394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. V1 vs. combined V1+V2 vasopressin blockade after hemorrhage in conscious dogs.
    Liard JF
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1325-9. PubMed ID: 2974249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel vasopressin peptide lowers blood pressure through decreases in cardiac output.
    Yu M; Ghosh M; McNeill JR
    Can J Physiol Pharmacol; 2003 May; 81(5):497-501. PubMed ID: 12774857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic effects of arginine vasopressin in conscious water-deprived rats.
    Rascher W; Meffle H; Gross F
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H29-33. PubMed ID: 4014485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a vasodilatory effect of vasopressin in the conscious rat.
    Walker BR
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H34-9. PubMed ID: 3755295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats.
    Claria J; Jiménez W; Arroyo V; Guarner F; López C; La Villa G; Asbert M; Rivera F; Rodés J
    Gastroenterology; 1989 Nov; 97(5):1294-9. PubMed ID: 2792662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
    Ishikawa S; Kim JK; Schrier RW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):R713-9. PubMed ID: 6688929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure.
    Nicod P; Waeber B; Bussien JP; Goy JJ; Turini G; Nussberger J; Hofbauer KG; Brunner HR
    Am J Cardiol; 1985 Apr; 55(8):1043-7. PubMed ID: 3885704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
    Naitoh M; Suzuki H; Murakami M; Matsumoto A; Arakawa K; Ichihara A; Nakamoto H; Oka K; Yamamura Y; Saruta T
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2245-54. PubMed ID: 7810724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs.
    Schwartz J; Liard JF; Ott C; Cowley AW
    Am J Physiol; 1985 Nov; 249(5 Pt 2):H1001-8. PubMed ID: 3840655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin analogs that antagonize antidiuretic responses by rats to the antidiuretic hormone.
    Sawyer WH; Pang PK; Seto J; McEnroe M; Lammek B; Manning M
    Science; 1981 Apr; 212(4490):49-51. PubMed ID: 7209515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.
    Wada K; Fujimori A; Matsukawa U; Arai Y; Sudoh K; Yatsu T; Sasamata M; Miyata K
    Eur J Pharmacol; 2005 Jan; 507(1-3):145-51. PubMed ID: 15659304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoconstrictor role for vasopressin in conscious, sodium-depleted rats.
    Jover B; Dupont M; Mimran A; Woods R; McGrath B
    Am J Physiol; 1987 Oct; 253(4 Pt 2):H763-9. PubMed ID: 2889370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasopressin and vasopressin-antagonists applied to neonatal Wistar rats: effects on body and brain development and water metabolism.
    Snijdewint FG; Boer GJ
    Neurobehav Toxicol Teratol; 1986; 8(3):213-7. PubMed ID: 3736748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.